MedTrace Logo

Safety, Tolerability and Efficacy of HAVAI, for Correction of Inter-metatarsal Angle

NCT02831868 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-09-04

No results posted yet for this study

Summary

A non-inferiority study to demonstrate efficacy of the HAVAI minimally invasive device compared to standard of surgical care 1st metatarsal osteotomy (SSOC)

Conditions

  • Hallux Valgus

Interventions

DEVICE

HAVAI

implantation of the HAVAI device to correct the IMA angle

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Eyal Heller, MD · Rabin MC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2019-05-31
Completion
2019-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02831868 on ClinicalTrials.gov